ESR1 and breast cancer: Patients with interval breast cancer usually present with an average higher histological grade7,8, larger tumor size9, and more-metastatic local lymphnodes10, a higher proportion of estrogen receptor (ER)8/progesterone receptor (PR) negativity11, a higher frequency of HER2 positivity8,9, and are more often triple negative12.